Anti-obesity medication

Anti-obesity medication

The race to develop the next generation of weight-loss drugs

Novo Nordisk and Eli Lilly, plus a clutch of rivals, aim to cut side effects while treating obesity-linked diseases.

With obesity rates on the rise globally, pharmaceutical companies are in a race to develop more effective and safer weight-loss medications. Novo Nordisk and Eli Lilly, along with other competitors, are working on groundbreaking drugs that not only help individuals lose weight but also treat obesity-related diseases. These advancements in medication could potentially revolutionize the way obesity is managed and improve the overall health of millions of people.